Want to see SGMT full AI Analyst Report?
Sagimet Biosciences, Inc. Class A (SGMT) Ownership Overview
5.34% Insiders
6.72% Mutual Funds
0.38% Other Institutional Investors
11.90% ETFs
75.66% Public Companies and Individual Investors
The ownership structure of Sagimet Biosciences, Inc. Class A (SGMT) stock is a mix of institutional, retail, and individual investors. Approximately 19.00% of the company’s stock is owned by Institutional Investors, 5.34% is owned by Insiders, and 75.66% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 22, 2026 | xxxxxxxxxxxxx | $497036 | |
Jul 22, 2026 | xxxxxxxxxxxxx | $81829 | |
Feb 12, 2026 | xxxxxxxxxxxxx | $64861 | |
Feb 12, 2026 | xxxxxxxxxxxxx | $7032 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,923,481 | Institution | 4.78% | 20,785,950 | |
| 2,760,736 | Institution | 4.51% | 19,628,833 | |
| 2,083,333 | Institution | 3.41% | 14,812,498 | |
| 2,031,118 | Insider | 3.32% | 14,441,249 | |
| 1,113,029 | Institution | 1.82% | 7,913,636 | |
| 1,069,101 | Institution | 1.75% | 7,601,308 | |
| 1,000,943 | Institution | 1.64% | 7,116,705 | |
| 952,996 | Institution | 1.56% | 6,775,802 | |
| 741,570 | Insider | 1.21% | 5,272,563 | |
| 293,441 | Institution | 0.48% | 2,086,366 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,083,333 | Institution | 3.41% | 14,812,498 | |
| 1,069,101 | Institution | 1.75% | 7,601,308 | |
| 293,441 | Institution | 0.48% | 2,086,366 | |
| 267,232 | Institution | 0.44% | 1,900,020 | |
| 185,000 | Institution | 0.30% | 1,315,350 | |
| 115,290 | Institution | 0.19% | 819,712 | |
| 33,033 | Institution | 0.05% | 234,865 | |
| 15,559 | Institution | 0.03% | 110,624 | |
| 14,259 | Institution | 0.02% | 101,381 | |
| 12,731 | Institution | 0.02% | 90,517 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,861,227 | Institution | 3.04% | 14,387,285 | |
| 1,472,593 | Institution | 2.41% | 12,870,463 | |
| 974,911 | Institution | 1.59% | 8,423,231 | |
| 658,772 | Institution | 1.08% | 5,092,308 | |
| 424,560 | Institution | 0.69% | 3,710,654 | |
| 422,700 | Institution | 0.69% | 3,694,398 | |
| 337,803 | Institution | 0.55% | 2,611,217 | |
| 198,202 | Institution | 0.32% | 1,732,285 | |
| 136,754 | Institution | 0.22% | 1,181,555 | |
| 117,195 | Institution | 0.19% | 1,024,284 |
FAQ
Who Owns Sagimet Biosciences, Inc. Class A (SGMT)?
According to the latest TipRanks data, approximately 0.38% of the company's stock is held by institutional investors, 5.34% is held by insiders, and 75.66% is held by retail investors.
What percentage of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.38% of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by institutional investors.
What percentage of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.66% of Sagimet Biosciences, Inc. Class A (SGMT) stock is held by retail investors.
Who owns the most shares of Sagimet Biosciences, Inc. Class A (SGMT)?
Vanguard owns the most shares of Sagimet Biosciences, Inc. Class A (SGMT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.